Chronic wounds are characterized by their inability to heal within an expected time frame
and have emerged as an increasingly important clinical problem over the past several …

Skin injuries across the body continue to disrupt everyday life for millions of patients and
result in prolonged hospital stays, infection, and death. Advances in wound healing devices …

Engineering a proper immune response following biomaterial implantation is essential to
bone tissue regeneration. Herein, a biomimetically hierarchical scaffold composed of …

Foot ulcers are one of the most common and severe complication of diabetes mellitus with
significant resultant morbidity and mortality. Multiple factors impair wound healing include …

Deferoxamine B is an outstanding molecule which has been widely studied in the past
decade for its ability to bind iron and many other metal ions. The versatility of this metal …

The treatment of wounds is expensive and challenging. Most of the available wound
dressings are not effective and suffer from limitations such as poor antimicrobial activity …

Chronic non-healing diabetic wounds and ulcers can be fatal, lead to amputations, and
remain a major challenge to medical, and health care sectors. Susceptibility to infection and …

Delayed injured nerve regeneration remains a clinical problem, partly ascribing to the lack of
regulation of regenerative microenvironment, topographical cues, and blood nourishment …

Deferoxamine mesylate (DFO) is an FDA-approved, hexadentate iron chelator routinely
used to alleviate systemic iron burden in thalassemia major and sickle cell patients. Iron …

Ferroptosis plays an essential role in the development of diabetes and its complications,
suggesting potential therapeutic strategies targeting ferroptosis. Secretory autophagosomes …